Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mathijssen

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Tijdschrift Voor Psychiatrie|August 20, 2024
[Tapering maintenance treatment for bipolar disorders]A Dols, H Mathijssen, R W Kupka, et al.
The Science of the Total Environment|June 4, 2019
Plant communities control long term carbon accumulation and biogeochemical gradients in a Patagonian bogPaul J H Mathijssen, Mariusz Gałka, Werner Borken, et al.
Clinical Pharmacology and Therapeutics|July 24, 2009
Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicityK K Filipski, R H Mathijssen, T S Mikkelsen, et al.
Global Change Biology|April 4, 2022
Identifying main uncertainties in estimating past and present radiative forcing of peatlandsPaul J H Mathijssen, Juha-Pekka Tuovinen, Annalea Lohila, et al.
Clinical Pharmacology and Therapeutics|May 30, 2008
Influence of solute carriers on the pharmacokinetics of CYP3A4 probesR M Franke, S D Baker, R H Mathijssen, et al.
Clinical Pharmacology and Therapeutics|April 27, 2012
Associations between ABCC2 polymorphisms and cisplatin disposition and efficacyJ A Sprowl, V Gregorc, C Lazzari, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 22, 2018
Development and validation of an analytical method for regorafenib and its metabolites in mouse plasmaQiang Fu, Mingqing Chen, Shuiying Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)R H Mathijssen, R J van Alphen, J Verweij, et al.
Respiratory Medicine|March 1, 2022
Four-year survival rate in pulmonary sarcoidosis with extensive pulmonary hypertension screeningM P Huitema, H Mathijssen, A L M Bakker, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-seriesH Mathijssen, M P Huitema, A L M Bakker, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Tijdschrift Voor Psychiatrie|August 20, 2024
[Tapering maintenance treatment for bipolar disorders]A Dols, H Mathijssen, R W Kupka, et al.
The Science of the Total Environment|June 4, 2019
Plant communities control long term carbon accumulation and biogeochemical gradients in a Patagonian bogPaul J H Mathijssen, Mariusz Gałka, Werner Borken, et al.
Clinical Pharmacology and Therapeutics|July 24, 2009
Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicityK K Filipski, R H Mathijssen, T S Mikkelsen, et al.
Global Change Biology|April 4, 2022
Identifying main uncertainties in estimating past and present radiative forcing of peatlandsPaul J H Mathijssen, Juha-Pekka Tuovinen, Annalea Lohila, et al.
Clinical Pharmacology and Therapeutics|May 30, 2008
Influence of solute carriers on the pharmacokinetics of CYP3A4 probesR M Franke, S D Baker, R H Mathijssen, et al.
Clinical Pharmacology and Therapeutics|April 27, 2012
Associations between ABCC2 polymorphisms and cisplatin disposition and efficacyJ A Sprowl, V Gregorc, C Lazzari, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 22, 2018
Development and validation of an analytical method for regorafenib and its metabolites in mouse plasmaQiang Fu, Mingqing Chen, Shuiying Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)R H Mathijssen, R J van Alphen, J Verweij, et al.
Respiratory Medicine|March 1, 2022
Four-year survival rate in pulmonary sarcoidosis with extensive pulmonary hypertension screeningM P Huitema, H Mathijssen, A L M Bakker, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-seriesH Mathijssen, M P Huitema, A L M Bakker, et al.
Pageof 4